Влияние средств метаболической терапии на сосудистый гомеостаз у больных с коморбидной бронхокардиальной патологией
Віктор Миколайович Погорєлов, Н.Д. Телегина, Valeria V. Brek et al. · Experimental and Clinical Medicine · 2017
The study involved 45 patients with chronic obstructive pulmonary disease with stable stenocardia treated by complex therapy. Including amlodipine (group of comparison) and 19 of them also were treated by meldonium + γ-butirobetain dihydrate (main group). There were studied hemodynamics, cytokine profile and changes of nitric oxide and platelet-vascular hemostasis. After treatment, there was a decrease of pressure in pulmonary artery, increase percent of ejection fraction and accompanied by decrease in the level of endothelin-1, interleukin-1, tumor necrosis factor and platelets aggregation ability, increase of nitric oxide. Received positive clinical and laboratory dynamics were more in the main group than in the comparison one.
Cited by 0 works.